Inhibition of HTRA2 activity, particularly the catalytic protein domain, prevented myocardial dysfunction and inflammation-mediated tissue damaging events after ischemia/reperfusion injury in rat hearts in vivo [62]. The gene discussed is HTRA2; the disease is ischemia.